Preskoči na vsebino

Hematologija

Management and Optimization of Hemostasis

Recombinant Activated Factor VII (rFVIIa)

Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. (odpre novo okno)

Gerotziafas GT, Zervas C, Gavrielidis G, Tokmaktsis A, Hatjiharissi E, Papaioannou M, Lazaridou A, Constantinou N, Samama MM, Christakis J.

Vir‎: Am J Hematol 2002;69(3):219-22.

Indeksirano‎: PubMed 11891811

https://www.ncbi.nlm.nih.gov/pubmed/11891811 (odpre novo okno)

Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature. (odpre novo okno)

Salama A, Rieke M, Kiesewetter H, von Depka M.

Vir‎: Ann Hematol 2009;88(1):11-5.

Indeksirano‎: PubMed 18787824

DOI‎: 10.1007/s00277-008-0608-3

https://www.ncbi.nlm.nih.gov/pubmed/18787824 (odpre novo okno)